0001973379-24-000102.txt : 20240307 0001973379-24-000102.hdr.sgml : 20240307 20240307113151 ACCESSION NUMBER: 0001973379-24-000102 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 24728769 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Bodenhoff Mads CENTRAL INDEX KEY: 0002014697 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ASCENDIS PHARMA A/S STREET 2: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 144 1 primary_doc.xml 144 0002014697 XXXXXXXX LIVE 0001612042 Ascendis Pharma A/S 001-36815 TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44 Bodenhoff Mads Officer Chief Accounting Officer Ordinary Shares Citigroup Global Markets Inc.

390 Greenwich Street New York NY 10013

2225 337170.36 57707439 03/04/2024 NASDAQ Ordinary Shares 03/04/2024 Restricted Stock Vesting Ascendis Pharma A/S N 2225 03/04/2024 Services Rendered Y The sales were completed according to 10B5-1 plans entered into in September 2023, for the sale of shares in connection to RSUs and PSUs vesting. 03/07/2024 Conformed Signature on File